News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Bethel Adefres: The 2024 World Congress of Brachytherapy
Photo from Bethel Adefres/X
Jul 24, 2024, 00:56

Bethel Adefres: The 2024 World Congress of Brachytherapy

Bethel Adefres, Radiation Oncologist at Yale University, shared on X:

“Last week at the 2024 World Congress of brachytherapy with mentors and friends, working together to raise awareness and advance this vital cancer treatment.”

Bethel Adefres

Source: Bethel Adefres/X

2024 World Congress of Brachytherapy Bethel Adefres cancer OncoDaily Oncology radiation oncology Yale University
Insight
Aug 18, 2024, 16:02
Isaac Kohane: AI can be the Great Leveller for cancer care
Insight
Aug 18, 2024, 15:58
SIOP Programs Update - July 2024
Insight
Aug 18, 2024, 15:54
Andrea Maliachi: The p value, its limitations and misleading use in medical research
Insight
Aug 18, 2024, 15:44
Amanda Nickles Fader: It’s a great time to become a FWC scholar
Blog
Aug 18, 2024, 15:27
Cheng Ean Chee: Privileged to co-chair the HCC session at the Singapore Hepatology Conference
Blog
Aug 18, 2024, 15:24
Aruni Ghose: The Best Team that I’ve worked with when it comes to Cancer Reach and Coverage
Blog
Aug 18, 2024, 15:17
EM Oncology team participating in ESMO 24 - Dr. Reddy's Laboratories
Blog
Aug 18, 2024, 15:16
CCR researchers have created a massive data resource for treating lung cancer - NCI Center for Cancer Research
Blog
Aug 18, 2024, 15:13
Modupe Elebute-Odunsi: Community Engagement to Increase Cancer Prevention Awareness
Blog
Aug 18, 2024, 15:10
Sami Mansfield: An excellent read from our UK colleagues about cancer risks and prevention
Blog
Aug 18, 2024, 15:09
Hil Moss: Cancer risk in Gen X/Millennials is both harrowing and a critical read
Blog
Aug 18, 2024, 15:03
Jorge Cortes: Olutasidenib among patients with R/R AML mIDH1 previously treated with venetoclax